Factor VIII inhibitor development in Egyptian hemophilia patients: does intron 22 inversion mutation play a role?

被引：0
作者：
Laila M. Sherief
Osama A. Gaber
Hala Mosaad Youssef
Hanan S. Sherbiny
Wesam a Mokhtar
Asmaa A. A. Ali
Naglaa M. Kamal
Yehia H. Abdel Maksoud
机构：
[1] Zagazig University,Pediatric Department, Faculty of Medicine
[2] Zagazig University,Biochemistry Department, Faculty of Medicine
[3] University of Bisha (UB),Pediatric Department, Collage of Medicine
[4] Cairo University,Pediatric Department, Faculty of Medicine
[5] Benha University,Pediatric Department, Faculty of Medicine
来源：
Italian Journal of Pediatrics | / 46卷
关键词：
Factor VIII inhibitor; Hemophilia; Intron 22 inversion mutation; Children;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 28 条
  • [21] Prevalence of IVS10nt-18G/A in Calabrian patients with moderate/mild hemophilia A and relation with Factor VIII inhibitor antibodies
    Prejano, Simona
    Santoro, Rita C.
    Iannaccaro, Piergiorgio
    BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (07) : 750 - 754
  • [22] Acquired hemophilia: A case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature
    Alvarado, Yesid
    Yao, Xin
    Jumper, Cynthia
    Hardwicke, Fred
    D'Cunha, Nicholas
    Cobos, Everardo
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2007, 13 (04) : 443 - 448
  • [23] Potential Role of Thrombelastography in the Monitoring of Acquired Factor VIII Inhibitor Hemophilia A: Report on a 78-year-old Woman With Life-threatening Bleedings
    Spiezia, Luca
    Meneghetti, Leonardo
    Valle, Fabio Dalla
    Tognin, Giulio
    Radu, Claudia
    Saggiorato, Graziella
    Fadin, Mariangela
    Zanon, Ezio
    Simioni, Paolo
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2009, 15 (04) : 470 - 476
  • [24] Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies
    Volkers, Peter
    Hanschmann, Kay-Martin
    Calvez, Thierry
    Chambost, Herve
    Collins, Peter W.
    Demiguel, Virginie
    Hart, Daniel P.
    Hay, Charles R. M.
    Goudemand, Jenny
    Ljung, Rolf
    Palmer, Ben P.
    Santagostino, Elena
    van Hardeveld, Ella M.
    van den Berg, Marijke
    Keller-Stanislawski, Brigitte
    HAEMOPHILIA, 2019, 25 (03) : 398 - 407
  • [25] Reduced plasma factor X is associated with a lack of response to recombinant activated factor VII in patients with hemophilia A and inhibitor, but does not impair emicizumab-driven hemostasis in vitro
    Yada, Koji
    Fujitate, Natsume
    Ogiwara, Kenichi
    Soeda, Tetsuhiro
    Kitazawa, Takehisa
    Nogami, Keiji
    THROMBOSIS RESEARCH, 2024, 237 : 37 - 45
  • [26] Development of a Single-Tube Reverse Transcription Real-Time PCR Assay for Diagnosis of F8 Intron 22 Inversion in Patients and Carriers of Haemophilia A
    Arzuaga-Mendez, Javier
    Insunza, Lucia
    Ojinaga, Maria Jose
    Moreto, Ana
    Moreno-Gamiz, Maite
    Vara-Pampliega, Miriam
    Garcia-Ruiz, Juan Carlos
    Sierra-Aisa, Cristina
    HAEMOPHILIA, 2025, 31 (02) : 263 - 268
  • [27] Commentary on "Development of a novel fully functional coagulation factor VIII with reduced immunogenicity utilizing an in silico prediction and deimmunization approach" - Will we ever be able to avoid inhibitor formation in hemophilia A? COMMENT
    Hart, Daniel P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (09) : 2125 - 2126
  • [28] Scoliosis in Patients with Aortic Coarctation and Patent Ductus Arteriosus: Does Standard Posterolateral Thoracotomy Play a Role in the Development of the Lateral Curve of the Spine?
    Roclawski, Marek
    Sabiniewicz, Robert
    Potaz, Piotr
    Smoczynski, Andrzej
    Pankowski, Rafal
    Mazurek, Tomasz
    Daibo, Bawo
    PEDIATRIC CARDIOLOGY, 2009, 30 (07) : 941 - 945
123